Literature DB >> 15086371

Are there characteristics of infectious diseases that raise special ethical issues?

Charles B Smith1, Margaret P Battin, Jay A Jacobson, Leslie P Francis, Jeffrey R Botkin, Emily P Asplund, Gretchen J Domek, Beverly Hawkins.   

Abstract

This paper examines the characteristics of infectious diseases that raise special medical and social ethical issues, and explores ways of integrating both current bioethical and classical public health ethics concerns. Many of the ethical issues raised by infectious diseases are related to these diseases' powerful ability to engender fear in individuals and panic in populations. We address the association of some infectious diseases with high morbidity and mortality rates, the sense that infectious diseases are caused by invasion or attack on humans by foreign micro-organisms, the acute onset and rapid course of many infectious diseases, and, in particular, the communicability of infectious diseases. The individual fear and community panic associated with infectious diseases often leads to rapid, emotionally driven decision making about public health policies needed to protect the community that may be in conflict with current bioethical principles regarding the care of individual patients. The discussion includes recent examples where dialogue between public health practitioners and medical-ethicists has helped resolve ethical issues that require us to consider the infected patient as both a victim with individual needs and rights and as a potential vector of disease that is of concern to the community.

Entities:  

Keywords:  Health Care and Public Health

Mesh:

Substances:

Year:  2004        PMID: 15086371     DOI: 10.1111/j.1471-8731.2004.00064.x

Source DB:  PubMed          Journal:  Dev World Bioeth        ISSN: 1471-8731            Impact factor:   2.294


  9 in total

1.  Expanding ICU facilities in an epidemic: recommendations based on experience from the SARS epidemic in Hong Kong and Singapore.

Authors:  Charles D Gomersall; Dessmon Y H Tai; Shi Loo; James L Derrick; Mia Siang Goh; Thomas A Buckley; Catherine Chua; Ka Man Ho; Geeta P Raghavan; Oi Man Ho; Lay Beng Lee; Gavin M Joynt
Journal:  Intensive Care Med       Date:  2006-03-29       Impact factor: 17.440

2.  Exploring ethical considerations for the use of biological and physiological markers in population-based surveys in less developed countries.

Authors:  Gregory Pappas; Adnan A Hyder
Journal:  Global Health       Date:  2005-11-28       Impact factor: 4.185

3.  Ethical issues in microbiome research and medicine.

Authors:  Rosamond Rhodes
Journal:  BMC Med       Date:  2016-10-12       Impact factor: 8.775

4.  Pre-pandemic planning survey of healthcare workers at a tertiary care children's hospital: ethical and workforce issues.

Authors:  Jessica Cowden; Lori Crane; Dennis Lezotte; Jacqueline Glover; Ann-Christine Nyquist
Journal:  Influenza Other Respir Viruses       Date:  2010-07       Impact factor: 4.380

5.  Strengthening Public Health Partnerships in India: Envisioning the Role of Law Enforcement During Public Health Emergencies.

Authors:  Rachit Sharma; Md Mahbub Hossain
Journal:  Indian J Community Med       Date:  2019 Jul-Sep

6.  Guiding organisational decision-making about COVID-19 asymptomatic testing in workplaces: mixed-method study to inform an ethical framework.

Authors:  Jan W van der Scheer; Akbar Ansari; Meredith McLaughlin; Caitríona Cox; Kathleen Liddell; Jenni Burt; Jenny George; Rebecca Kenny; Ruth Cousens; Brandi Leach; James McGowan; Katherine Morley; Janet Willars; Mary Dixon-Woods
Journal:  BMC Public Health       Date:  2022-09-15       Impact factor: 4.135

Review 7.  Who should be tested in a pandemic? Ethical considerations.

Authors:  Sven Ove Hansson; Gert Helgesson; Niklas Juth
Journal:  BMC Med Ethics       Date:  2021-06-22       Impact factor: 2.652

Review 8.  Psychosocial consequences of infectious diseases.

Authors:  G Pappas; I J Kiriaze; P Giannakis; M E Falagas
Journal:  Clin Microbiol Infect       Date:  2009-08       Impact factor: 8.067

9.  Pandethics.

Authors:  M J Selgelid
Journal:  Public Health       Date:  2009-02-14       Impact factor: 2.427

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.